Thoracic: Lung CancerClinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non–small cell lung cancer
Under an Elsevier user license
open archive
Graphical abstract
Key Words
clinical stage IA
ground-glass opacity
non–small cell lung cancer
pure solid
Abbreviations and Acronyms
CI
confidence interval
CT
computed tomography
CTR
consolidation tumor ratio
GGO
ground-glass opacity
HR
hazard ratio
NSCLC
non–small cell lung cancer
OS
overall survival
RFS
recurrence-free survival
SUVmax
maximum standardized uptake value
Cited by (0)
This work was supported in by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan, the Smoking Research Foundation, and the National Cancer Center Research and Development Fund (26-A-4).
Read at the Twenty-sixth European Conference on General Thoracic Surgery, Ljubljana, Slovenia, May 27-30, 2018.
© 2020 by The American Association for Thoracic Surgery